Franklin Lakes-based BD (Becton, Dickinson and Co.) said May 6 it plans to separate its Diabetes Care business into an independent publicly-traded company (“NewCo”). Polen “The decision to spin off ...
In May, BD announced it would create an independent, publicly traded company for its Diabetes Care business. Now, it’s formally introducing the entity as “embecta.” According to the Franklin ...
After nearly a century spent building out its portfolio of insulin pens and syringes, BD is finally ready to let its diabetes care business leave the nest. While reporting financial results for the ...
(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced that it has selected "embecta" as the name of the independent, publicly-traded company that will hold BD's ...
Standalone Diabetes Care business expected to leverage position as global leader in insulin delivery and expand presence in large and high-growth diabetes market - Spinoff allows both BD and NewCo to ...
BD, a leading global medical technology company, recently announced that its board of directors has approved the planned spinoff of its diabetes care business, which will be known as Embecta. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback